Bumetanide in Hypokalaemic Periodic Paralysis: A Randomised, Double-Blind, Placebo Controlled Phase II Clinical Trial With a Crossover Design
Neuromuscular Disorders - United Kingdom
doi 10.1016/j.nmd.2016.06.402
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Elsevier BV